Caissa Capital Management ltd. - 24 May 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
10%+ Owner
Signature
Cambyz Golestaneh, Title: Director
Issuer symbol
AVTX
Transactions as of
24 May 2023
Net transactions value
+$26,816
Form type
4
Filing time
24 May 2023, 16:15:01 UTC
Previous filing
22 May 2023
Next filing
30 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $10,468 +3,481 +0.25% $3.01* 1,377,181 24 May 2023 See Footnote (1) F1, F2
transaction AVTX Common Stock Purchase $16,348 +5,519 +0.4% $2.96* 1,382,700 24 May 2023 See Footnote (1) F1, F3
holding AVTX Common Stock 182,300 24 May 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.0 to $3.01, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.92 to $3.03, inclusive.
F4 These shares are directly owned by Mr. Golestaneh in his personal capacity.